---
title: "The latest research findings support Harvard's discovery: Novo Nordisk's weight loss drug Ozempic is associated with rare visual loss"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/222302525.md"
description: "Recent research indicates that Novo Nordisk's weight loss drug Ozempic is associated with rare visual loss (NAION), with obese patients using the drug being diagnosed with NAION at more than twice the rate. Although the risk of the eye condition remains relatively low, patients should remain vigilant. Novo Nordisk's stock price once fell by more than 3.3%"
datetime: "2024-12-13T16:02:56.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/222302525.md)
  - [en](https://longbridge.com/en/news/222302525.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/222302525.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/222302525.md) | [繁體中文](https://longbridge.com/zh-HK/news/222302525.md)


# The latest research findings support Harvard's discovery: Novo Nordisk's weight loss drug Ozempic is associated with rare visual loss

Large-scale trial results indicate that Novo Nordisk's weight loss drug Ozempic is associated with rare visual loss, supporting earlier research findings from Harvard University this year. Obese patients using Ozempic are more than twice as likely to be diagnosed with NAION. NAION occurs when reduced blood flow damages the visual nerve. The risk of this eye condition remains low; patients should be vigilant. Novo Nordisk's stock price in Denmark once fell over 3.3%.

Risk Warning and Disclaimer

The market carries risks, and investments should be made cautiously. This article does not constitute personal investment advice and does not take into account the specific investment goals, financial situation, or needs of individual users. Users should consider whether any opinions, views, or conclusions in this article align with their specific circumstances. Investment based on this is at one's own risk

### Related Stocks

- [Novo Nordisk A/S (NVO.US)](https://longbridge.com/en/quote/NVO.US.md)
- [Eli Lilly and Company (LLY.US)](https://longbridge.com/en/quote/LLY.US.md)
- [NUODE (600110.CN)](https://longbridge.com/en/quote/600110.CN.md)
- [IB SETTLEMENT (00147.HK)](https://longbridge.com/en/quote/00147.HK.md)

## Related News & Research

- [Novo Nordisk A/S $NVO Shares Purchased by Heirloom Wealth Management](https://longbridge.com/en/news/281345767.md)
- [British drug-cost watchdog recommends use of Novo's Wegovy to lower heart risks](https://longbridge.com/en/news/281263193.md)
- [5 Simple ETFs to Buy With $1,000 and Hold for a Lifetime](https://longbridge.com/en/news/281345615.md)
- [BREAKINGVIEWS-A Trump no-deal Iran exit may leave lasting scars](https://longbridge.com/en/news/281361691.md)
- [BUZZ-Rosenblatt says finding partner for Snap's smart glasses unit tough](https://longbridge.com/en/news/281357569.md)